Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3Completed 2Active not recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 217Neoplasms 196Carcinoma, Non-Small-Cell Lung 94Colorectal Neoplasms 92Prostatic Neoplasms 79Lung Neoplasms 74Multiple Myeloma 49Head and Neck Neoplasms 48Neoplasm Metastasis 46Melanoma 46Pancreatic Neoplasms 44Leukemia, Myeloid, Acute 41Carcinoma, Hepatocellular 41Recurrence 35Brain Neoplasms 35Squamous Cell Carcinoma of Head and Neck 34Ovarian Neoplasms 32Glioblastoma 30Uterine Cervical Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Sarcoma 27Glioma 27Lymphoma, Non-Hodgkin 26Lymphoma 26Stomach Neoplasms 25Carcinoma, Renal Cell 25Lymphoma, Follicular 24Colonic Neoplasms 24Motor Activity 22Esophageal Neoplasms 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Overweight × 90 days × Clear all
NCT07513259 2026-04-07

Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

Chung Shan Medical University

Completed
203,424 enrolled
Other

Diabetes Mellitus, Type 2, Neoplasms, Obesity, Overweight

NCT04304924 2026-04-01

MEDEA

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Completed
220 enrolled

Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡